You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Donor LymphocyteI Infusion

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematopoietic Organs; Disorder Trial in Hong Kong (CD62L depleted donor lymphocyte infusion)

Recruiting
  • Hematopoietic Organs; Disorder
  • CD62L depleted donor lymphocyte infusion
  • Hong Kong, Hong Kong
    Hong Kong Children's Hospital
Sep 6, 2023

AML/MDS Trial in Copenhagen (iDLI)

Recruiting
  • AML/MDS
  • iDLI
  • Copenhagen, Denmark
    Copenhagen University Hospital, Rigshospitalet
Jan 13, 2023

Relapsed Adult ALL, Relapsed Adult AML Trial in Changchun (Plerixafor)

Active, not recruiting
  • Relapsed Adult ALL
  • Relapsed Adult AML
  • Changchun, Jilin, China
    First Hospital of Jilin University
Nov 19, 2023

Leukemia Trial (Donor Enriched Activated Natural Killer Cell Infusion)

Withdrawn
  • Leukemia
  • Donor Enriched Activated Natural Killer Cell Infusion
  • (no location specified)
Dec 20, 2022

Hematologic Tumors Trial run by the NCI (donor lymphocyte infusion, Cyclophosphamide, Busulfan)

Suspended
  • Hematologic Neoplasms
  • donor lymphocyte infusion
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 30, 2022

Living Donor Liver Transplantation Trial in Pittsburgh (Donor-derived DCreg)

Active, not recruiting
  • Living Donor Liver Transplantation
  • Donor-derived DCreg
  • Pittsburgh, Pennsylvania
    UPMC
Sep 7, 2022

Renal Failure Trial in Chicago, Louisville (Enriched Hematopoietic Stem Cell Infusion)

Active, not recruiting
  • Renal Failure
  • Enriched Hematopoietic Stem Cell Infusion
  • Chicago, Illinois
  • +1 more
Jul 15, 2022

Renal Failure Trial in Chicago (Biological/Vaccine: Enriched Hematopoetic Stem Cell Infusion)

No longer available
  • Renal Failure
  • Biological/Vaccine: Enriched Hematopoetic Stem Cell Infusion
  • Chicago, Illinois
    Northwestern Memorial Hospital
Jul 15, 2022

Kidney Failure Trial in Chicago, Durham (Enriched Hematopoietic Stem Cell Infusion)

Active, not recruiting
  • Kidney Failure
  • Enriched Hematopoietic Stem Cell Infusion
  • Chicago, Illinois
  • +1 more
Jul 15, 2022

Immunodeficiency Trial in Charlotte (Infusion of donor lymphocytes)

Terminated
Has Results
  • Immunodeficiency
  • Infusion of donor lymphocytes
  • Charlotte, North Carolina
    Levine Children's Hospital, Carolinas Medical Center
Apr 20, 2022

Hematologic Malignancy Trial in Tuebingen,, Tuebingen (CD45RA depleted donor lymphocyte infusion (DLI))

Recruiting
  • Hematologic Malignancy
  • CD45RA depleted donor lymphocyte infusion (DLI)
  • Tuebingen,, Germany
  • +1 more
Jul 13, 2023

Hematologic Malignancy Trial in Saint Petersburg (Prophylactic Donor lymphocytes infusions, Preventive Donor lymphocytes

Recruiting
  • Hematologic Malignancy
  • Prophylactic Donor lymphocytes infusions
  • Preventive Donor lymphocytes infusions
  • Saint Petersburg, Russian Federation
    RM Gorbacheva Research Institute
Aug 16, 2021

Acute Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial (Siremadlin)

Recruiting
  • Acute Myeloid Leukemia
  • Allogeneic Stem Cell Transplantation
  • Tel Aviv, Israel
  • +2 more
Jan 23, 2023

Islet Transplantation Trial in Palo Alto (Infusion of recipient T regulatory cell, Infusion of concomitant Donor Derived

Not yet recruiting
  • Islet Transplantation
  • Infusion of recipient T regulatory cell
  • Infusion of concomitant Donor Derived Vertebral Bone Marrow
  • Palo Alto, California
    Stanford University
Jul 25, 2023

Minimal Residual Disease, Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Recurrent Adult Acute Myeloid

Completed
  • Minimal Residual Disease
  • +3 more
  • Daratumumab
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 2, 2022

Haematological Malignancies Trial in London, Manchester (CD25/71 allodepleted donor T-cells)

Completed
  • Haematological Malignancies
  • CD25/71 allodepleted donor T-cells
  • London, United Kingdom
  • +1 more
Jul 18, 2022

Leukemia, Stem Cell Transplantation Trial in Munich (FBTA05)

Withdrawn
  • Leukemia
  • Stem Cell Transplantation
  • Munich, Bavaria, Germany
    3. Medizinische Klinik, Klinikum rechts der Isar der TU München
Dec 5, 2022

Multiple Myeloma, CLL, Chronic Lymphocytic Leukemia Trial in Los Angeles (radiation, procedure, biological, drug)

Active, not recruiting
  • Multiple Myeloma
  • +4 more
  • Total Body Irradiation
  • +5 more
  • Los Angeles, California
    Cedars Sinai Medical Center
Dec 21, 2022

Allogeneic Disease, GVHD,Acute, Graft Failure Trial (WJ-MSC infusion)

Not yet recruiting
  • Allogeneic Disease
  • +2 more
  • WJ-MSC infusion
  • (no location specified)
May 4, 2023

Hematologic Malignancy Trial in Pavia, Rome, Turin (BPX-501 T cells, rimiducid)

Active, not recruiting
  • Hematologic Malignancy
  • Pavia, Italy
  • +2 more
Jul 10, 2022

Living Donor Kidney Transplantation Trial in Palo Alto, Chicago (Infusion of Donor Hematopoetic Stem Cells and Recipient Tregs)

Recruiting
  • Living Donor Kidney Transplantation
  • Infusion of Donor Hematopoetic Stem Cells and Recipient Tregs
  • Palo Alto, California
  • +1 more
May 6, 2022

COVID-19 Trial in Galdakao (convalescent plasma infusion covid 19)

Terminated
  • COVID-19
  • convalescent plasma infusion covid 19
  • Galdakao, Bizkaia, Spain
    Hospital Galdakao-Usansolo
Feb 18, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in New York (haplo-identical cells (donor), umbilical cord blood unit

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • haplo-identical cells (donor)
  • umbilical cord blood unit (CBU)
  • New York, New York
    Weill Cornell Medical College
Dec 14, 2022

Ewing Sarcoma, Neuroblastoma, Rhabdomyosarcoma Trial in Milwaukee (Allogeneic HCT, Donor NK Cell Infusion)

Active, not recruiting
  • Ewing Sarcoma
  • +4 more
  • Allogeneic HCT
  • Donor NK Cell Infusion
  • Milwaukee, Wisconsin
  • +1 more
Apr 5, 2022

Renal Transplantation, Mesenchymal Stem Cells Trial in Houston (Mesenchymal Stromal Stem Cells (MSCs) Infusion, Normal Saline

Recruiting
  • Renal Transplantation
  • Mesenchymal Stem Cells
  • Mesenchymal Stromal Stem Cells (MSCs) Infusion
  • Normal Saline (Placebo) Infusion
  • Houston, Texas
    Houston Methodist Hospital System
Mar 8, 2022